Logos Global Management LP Trevi Therapeutics, Inc. Transaction History
Logos Global Management LP
- $761 Million
- Q4 2024
A detailed history of Logos Global Management LP transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 1,250,000 shares of TRVI stock, worth $6.11 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
1,250,000
Previous 2,750,000
54.55%
Holding current value
$6.11 Million
Previous $9.19 Million
42.03%
% of portfolio
0.7%
Previous 1.22%
Shares
4 transactions
Others Institutions Holding TRVI
# of Institutions
114Shares Held
77.6MCall Options Held
218KPut Options Held
182K-
Nea Management Company, LLC Timonium, MD11.4MShares$55.6 Million3.46% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.7MShares$52.2 Million2.72% of portfolio
-
Viking Global Investors LP4.4MShares$21.5 Million0.06% of portfolio
-
Rubric Capital Management LP New York, NY4.21MShares$20.6 Million0.3% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.15MShares$20.3 Million0.04% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $285M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...